OXFORD, England--(BUSINESS WIRE)--ResMed, a leading innovator in sleep that has been changing lives for more than 25 years, announced today that their smarter sleep solution, the S+ by ResMed, is ...

Medical equipment maker ResMed will pay $37.5 million to resolve allegations brought by the Department of Justice (DOJ) that it paid kickbacks to durable medical equipment suppliers, sleep labs and ...

Resmed’s innovative CPAP mask is designed to make it easier for people to stick with their treatment and improve overall sleep health. The new mask has been awarded two Red Dot Awards for its ...

ResMed (RMD) shares have been edging slightly lower over the past week, giving investors a nudge to re-examine the company’s current position and longer-term potential. This move comes against a ...

ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.

ResMed achieved double-digit revenue and profit growth over the past 9 years, driven by continuous acquisitions and improving operating efficiencies. ResMed's capital efficiencies showed mixed results ...

ResMed has established itself as a key player in the sleep and respiratory care market, with a primary focus on devices for sleep apnea and other respiratory conditions. The company's consistent ...

ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the average ...

WELLINGTON (Reuters) - New Zealand's Fisher & Paykel Healthcare said on Monday that it could continue to sell its sleep apnea masks in Britain as a UK court had ruled that rival Resmed Inc's patent ...

ResMed is a dominant player in healthcare devices with strong margins, recurring revenues, and a near-monopoly, offering a compelling mix of value and growth. The company continually invests in R&D, ...

SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, ...